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Background: As discontinuation in in vitro fertilization (IVF) programs has been associated with a poor prognosis,
one hypothesis is that some couple-specific predictive factors in IVF may be shared with opposite effect by both
success (i.e. live birth) and treatment discontinuation processes. Our objective was to perform a joint analysis of
these two processes to examine the hypothesis of a link between the two processes.
Methods: Analyses were conducted on a retrospective cohort of 3,002 women who began IVF between 1998 and
2002 in two French IVF centers: a Parisian center and a center in a medium-sized city in central France. A shared
random effects model based on a joint modelization of IVF treatment success and discontinuation was used to
study the link between the two processes.
Results: Success and discontinuation processes were significantly linked in the medium-sized city center, whereas
they were not linked in the Parisian center. The center influenced risk of treatment discontinuation but not chance
of success. The well-known inverse-J relation between the woman’s age and chance of success was observed,
as expected. Risk of discontinuation globally increased as the woman’s age increased.
Conclusions: The link between success and discontinuation processes could depend on the fertility center.
In particular, the woman’s decision to pursue or to discontinue IVF in a particular center could depend on the
presence of other IVF centers in the surrounding area.Background
Discontinuation of in vitro fertilization (IVF) treatment
is common, whatever the technical or social manage-
ment of patients [1-3]. During recent years, studies con-
ducted in various countries such as the Netherlands,
Sweden and the United Kingdom have reported very
high rates of discontinuation in IVF programs, with 25%
to 50% of couples discontinuing treatment after the first
or second attempt [1,2,4-6]. In countries where the
financial costs of IVF must be mainly borne by the
couple, such as the United Kingdom and the United
States, the decision to continue or to discontinue IVF
treatment is probably strongly influenced by financial* Correspondence: penelope.troude@inserm.fr
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reproduction in any medium, provided the orissues [3]. In France, where couples receive financial
support for IVF treatment (limited to 4 attempts for one
pregnancy), discontinuation rates also appear to be high,
with estimated cumulative discontinuation rates of 46%
to 58% before the fourth attempt [7,8]. Treatment discon-
tinuation is thus not only a financial matter and may be
motivated by the heavy psychological or physical burden
of IVF treatment and/or by a poor prognosis [2,3].
In an English cohort study of 2,056 couples, the cha-
racteristics of patients who discontinued IVF treatment
after the first attempt were compared with those who
had a second IVF attempt [1]. Among couples who
discontinued IVF treatment, more women were aged
>35 years, had five or less oocytes retrieved at the
first attempt and two or less embryos available at the
first attempt [1]. All these factors were associated with
a lower chance of successful IVF. Other studies also
demonstrated common factors associated with successLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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factors in IVF treatment thus appeared to be shared by
both success and treatment discontinuation processes,
having an opposite impact on the two processes. For
example, as the woman’s age increases, the chance of
success decreases and, at the same time, the risk of treat-
ment interruption increases. Such a link between success
and treatment interruption is confirmed by studies
investigating reasons for IVF treatment discontinua-
tion. Even if the reason for treatment interruption is dif-
ficult to assess (it is probably a multifactorial decision,
and one that is often studied several years after interrup-
tion), these studies showed that one in four couples
considered that their treatment interruption was due
to a poor prognosis [2,3]. Such results demonstrate the
importance of studying discontinuation and success pro-
cesses together.
Our aim was to investigate conjointly treatment dis-
continuation and success processes in two IVF centers
and to examine the hypothesis that there is a link be-
tween the two processes in each center. We also aimed
to explore the effects of the woman’s age and of the IVF
center on the success process and on the discontinu-




The study was conducted in two French IVF centers: a
center located in Paris (Cochin) and a center located
in a medium-sized city in central France (Clermont-
Ferrand).
All women having their first aspiration in one of the
two centers between 1998 and 2002 were included in
the study (n= 3,037). Thirty-five women were excluded
because the result of the first attempt was unknown,
leaving 3,002 women. This study received approval from
the French Data Protection Authority in September
2005 (authorization number 05-1334).
Information was collected from medical records for all
aspirations undergone by the couples in the IVF center,
as well as data on frozen embryo transfer (FET), up to
2005. The couples’ characteristics collected included the
woman’s date of birth, date of aspiration, number of
oocytes retrieved, IVF technique used, number of fresh
embryos transferred, number of frozen embryos and the
result of transfer (pregnancy, delivery). As the French
social security system reimburses IVF treatment up to
four aspirations, data collection was discontinued after
the woman’s fourth aspiration.
Outcome measures
The success of IVF was measured by a live birth after
one attempt. The live birth rate was defined as a deliveryresulting from fresh or frozen embryo transfer among
women who had undergone one IVF attempt. Treatment
discontinuation was defined as no treatment for at least
two years in the IVF center (whatever the reason for
discontinuation, e.g. maternal age, financial resources,
move to another area, seeking IVF treatment else-
where. . .) [8,11,12]. Discontinuation rate was defined
as discontinuation among women who had not obtained
a live birth after the IVF attempt.
Descriptive statistics
Women’s characteristics at the first attempt were com-
pared according to inclusion center, using the chi 2 test.
Live birth rate and discontinuation rate at each attempt
were also compared according to inclusion center.
Shared random effects model
Success (live birth) and treatment discontinuation shared
factors that underlie a couple’s susceptibility to both
events (with opposite impact). These underlying shared
factors may represent for example psychological factors
and are difficult to measure. Conventional models (such
as Cox proportional hazards models or multinomial
models) do not make it possible to include such unmea-
sured shared factors. The concept of the shared random
effects model is to include a random effect representing
these shared unmeasured factors that impact on the two
processes. The shared random effects approach has been
described as “a very intuitive appeal to biomedical
researchers who generally believe that there may be
some latent quantity underlying a person’s susceptibility
to both disease and death” [13]. By analogy, in our study
“disease” is IVF success, and “death” is treatment discon-
tinuation. Thus, we used a shared random effects model
[14], composed of two mixed logistic regression models,
one for success (pi) and one for discontinuation ( πi )
where i represented the couple:
logit pið Þ ¼ αsucc þ βsuccagei þ βsucccenteri þ fi
logit πið Þ ¼ αdisc þ βdiscagei þ βdisccenteri þ λfi þ εi
These models included baseline factors (αsucc and αdisc).
They included two observed determinants called “fixed
effects”:
– the IVF center (Parisian center/medium-sized city
center) denoted βsucccenteri and β
disc
centeri
– and the woman’s age at the first attempt divided into
five classes (age <25/25-29/30-34/35-39/≥40 years)
denoted βsuccagei and β
disc
agei .
It also included a “random effect” ( fi) that is common
to both mixed logistic regression models. This shared
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* p-value for the chi2 test comparing the women’s characteristics according to
inclusion center.
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non-explicitly identified factors explaining both pro-
cesses. The coefficient associated with this shared ran-
dom effect (λ), could be interpreted as the “link”
between the two processes: if λ equals zero, it means
that there are no couple-specific factors (other than the
observed covariates included in the model) that simul-
taneously explain IVF success and treatment discontinu-
ation. On the contrary, if λ differs from zero, the
interpretation is that there are couple-specific non-
observed factors that determine both IVF success and
treatment discontinuation. When λ is strictly negative,
it means that these factors have an opposite relative
impact on the two processes. In our model, a specific λ
was considered for each center (λParis and λMedium-sized city)
in order to allow different degrees of “links” between the
two processes in the two IVF centers. Detailed information
on this model is given in the Additional file 1.
The shared random effects model was fitted with Bayesian
computational methods using Markov Chain Monte Carlo
(MCMC) [15] and implemented in WinBUGS [16]. We ran
two independent MCMC chains (using different initial
values for the parameters) of 300,000 simulations with a
burn-in period of 50,000 and kept every 100th to reduce
autocorrelation in the MCMC samples. Our results are
therefore based on thinned samples of size 5,000. Conver-
gence of the MCMC run was assessed by graphical inspec-
tion of the chains and by computing the Gelman-Rubin
statistics as modified by Brooks and Gelman [17,18] and
intra-chains autocorrelations. Credible intervals (95%)
were estimated. The λParis and λMedium-sized city parameters
were tested according to Bayesian statistical theory methods
using partial Bayes factors (BF) [19]: no evidence that λ 6¼ 0
if L=2logBF is greater than -2, λ significantly different from
0 if L≤ -2 and strongly different from 0 if L≤ -6.
We performed a Bayes factor sensitivity analysis to
prior choice of parameter distribution [19] and checked
the stability of our Bayesian method [20]. We computed
partial Bayes factors from more or less informative priors
(and only one MCMC run) by performing a split test
sample analysis as described elsewhere [20]. We consid-
ered three ways to split the sample of 3,002 women so
as to define a learning sample (i.e., 2,702, 1,502 and
502 women) that would be more or less informative on
the remaining test sample (i.e., 300, 1,500, 2,500 women).
Results
The characteristics of the study population at the first
aspiration are described in Table 1. The proportions
of patients in each of the two centers were similar, with
1,556 women having a first aspiration in the Parisian
center between 1998 and 2002 and 1,446 in the
medium-sized city center. Globally, median age at
first aspiration was 32 years. The women treated in theParisian center were somewhat older than women trea-
ted in the medium-sized city center (median age 33 vs
32 years), had more frozen embryos (p < 0.001) and
slightly fewer fresh embryos transferred (p < 0.001). The
ICSI technique was used more frequently in the Parisian
center than in the medium-sized city center (p < 0.001).
Global observed cumulative success rate (live birth)
was 37% (1,107/3,002); for the Parisian center, it was
34% and for the medium-sized city center 41%
(p < 0.001). Live birth rates per attempt decreased with
increasing number of attempts (Table 2) from 22% for
the first attempt in the Parisian center to 9% for the
fourth, and from 21% to 16% for the medium-sized city
center. Globally, 48% of women discontinued IVF treat-
ment (54% in the Parisian center, 42% in the medium-
sized city center, p < 0.001). The proportion of treatment
discontinuation increased with the increasing number of
attempts and was significantly higher in the Parisian
center at each attempt.
Table 2 Observed live birth and discontinuation rates in







n =1,556 (%) n =1,446 (%)
Live birth rate
1st attempt 22 21 ns
2nd attempt 18 19 ns
3rd attempt 9 17 0.002
4th attempt 9 16 0.066
Discontinuation rate
1st attempt 37 25 <0.001
2nd attempt 46 31 <0.001
3rd attempt 49 39 0.010
* p-value for the chi2 test comparing live birth rate and discontinuation rates
according to inclusion center.
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treatment discontinuation processes was estimated sep-
arately for each center with two coefficients being intro-
duced in the model, one for each center: λParis and
λMedium-sized city. Estimated λParis was very close to 0 where-
as that of λMedium-sized city was -0.21 (Table 3). The
95% credible interval for λMedium-sized city was skewed to-
ward negative values ([-0.5,0.0]) whereas that of λParis was
centered on 0 ([-0.2,0.2]). Comparison of models (Table 3,
see notes) showed that there was no evidence of a link be-
tween the success and discontinuation processes in the
Parisian center, whereas there was a significant negative
link in the medium-sized city center. Finally, Bayes factor
sensitivity to prior choices showed the stability of these
results. Indeed, λParis always appeared as non-significantly
differ-ent from 0 and λMedium-sized city always appeared as
significantly (and sometimes even strongly significantly)
different from 0.
Using this model, we studied the relationship between
success, discontinuation and the woman’s age. Results
are presented in Figure 1, with the 30-34 year old groupTable 3 Estimations of the links between the success
and treatment discontinuation processes for the Parisian






Test of λ b
λParis 0.01 (0.11) [-0.2,0.2] L = 2.70
c - NS
λMedium-sized city -0.21 (0.12) [-0.5,0.0] L = -5.26
d - S
a the models were adjusted for female age and center.
b using partial Bayes factors (see Methods section).
c The competitive models were M0: [λParis = 0 and λMedium-sized city =0] vs M1:
[λParis 6¼ 0 and λMedium-sized city =0 ]. There is a positive evidence against λParis 6¼ 0
meaning that λParis is non-significantly (NS) different from 0 (H0 is not rejected).
d The competitive models were M0: [λParis = 0 and λMedium-sized city = 0] vs M1:
[λParis = 0 and λMedium-sized city 6¼ 0]. There is a positive evidence against
λMedium-sized city =0 meaning that λMedium-sized city is significantly (S) different
from 0 (H0 is rejected).as reference. The chance of success varied as an inverse
J-shape with a maximum at age 25-29 years and a strong
decrease among older women (Figure 1a). The risk of
treatment discontinuation varied in the opposite direc-
tion with a minimum at age 30-34 years and a strong
increase among older women (Figure 1b).
The associations between IVF center and success and
treatment discontinuation are presented in Figure 2, with
the Parisian center as reference. The probability of suc-
cess did not differ according to IVF center (OR of success
was 0.97 with 95% credible interval [0.8;1.2]), whereas
women treated in the medium-sized city center had a
lower risk of treatment discontinuation than women
treated in the Parisian center (OR of treatment discon-
tinuation was 0.55 with 95% credible interval [0.5;0.7]).
Discussion
To study jointly success and treatment discontinuation
in IVF programs, a shared random effects model was
built and used to analyze data from two French IVF cen-
ters: a Parisian center and a medium-sized city center.
We found no evidence of a link between success and
discontinuation processes in the Parisian center, whereas
we did find one in the medium-sized city center. In the
medium-sized city center, the negative link observed
between the two processes meant that women who dis-
continued treatment in this center had a lower probabil-
ity of success. The direction of the link was expected
and is in agreement with the literature, as previous stud-
ies have reported poorer prognostic factors of IVF
success among women who discontinued treatment
[1,4,10]. However, it is interesting that no evidence of
such a link was observed in the Parisian center.
Woman’s age: effect on success and treatment
discontinuation
By defining success as a live birth during the entire IVF
program (first to fourth IVF attempts), we demonstrated
an inverse-J relationship between the woman’s age and
success. Such a relationship has already been shown
[21]. We also found that the probability of discontinu-
ation varied inversely to the probability of success
according to the woman’s age, and that the probability
of discontinuation globally increased with increasing fe-
male age. In our study, using women aged 30-34 years
as reference, OR of treatment discontinuation was 2.9
([2.2-3.7]) for women older than 40 years. A few studies
have already shown that women who discontinued treat-
ment were generally older that women who persevered
[22]. In our study, we assessed how the cumulative risk
of discontinuation alters with the woman’s age and
we demonstrated a J-relationship between the woman’s
age and cumulative risk of discontinuation during an
IVF program.
Figure 1 Estimated OR and boxplot a of the effect of the woman’s age on the success and treatment discontinuation processes
(reference age group was 30-34 years). a. Success b. Treatment discontinuation a median, upper and lower quartiles, and 95% credible
interval. Note: Bayesian estimations provide estimation of the distribution of the odds ratio (OR) and not one single punctual estimate. Consequently,
a box-plot is used to describe the estimated distribution of the OR with its quantiles 0.025, 0.25, 0.5 0.75 and 0.975.
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discontinuation
In our study, the crude cumulative success rate differed
according to center (34% vs 41%), but after controlling
for treatment discontinuation and the woman’s age, the
probability of success no longer differed between centers
(Figure 2). This result is similar to that of a study carried
out in two centers in the Netherlands [23]. Investigators
found that the crude cumulative live birth rates differed
between the two centers. However, this difference was
not due to differences in success rates at each attempt,
but rather to different discontinuation rates in each cen-
ter. These observations showed that comparison of IVFcenters should not be done on crude success rate and
that treatment discontinuation is an important factor
that should be taken into account.
Conversely, we found that treatment discontinuation
rates differed between centers, being lower in the
medium-sized city center. Moreover, a negative link was
found between success and discontinuation in the
medium-sized city center, whereas there was no evi-
dence of such a link in the Parisian center. One explan-
ation could be that the characteristics of women who
discontinued treatment differed between the two cen-
ters. In the medium-sized city center, the negative link
meant that women who discontinued had poorer
Figure 2 Estimated OR and boxplot a of the effect of the IVF center on the success and treatment discontinuation processes (Parisian
center as reference). a. Success b. Treatment discontinuation. a median, upper and lower quartiles, and 95% credible interval. Note: Bayesian
estimations provide estimation of the distribution of the odds-ratio (OR) and not one single punctual estimate. Consequently, a box-plot is used to
describe the estimated distribution of the OR with its quantiles 0.025, 0.25, 0.5 0.75 and 0.975.
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reason why women with poorer prognostic factors did
not discontinue treatment, but the higher level of dis-
continuation could indicate that women with good prog-
nostic factors also discontinued IVF treatment in the
Parisian center. This hypothesis of a more mixed popu-
lation could explain the lack of significant link between
success and discontinuation in the Parisian center. Dif-
ferences between fertility centers may be linked to vari-
ous factors such as patient selection, medical staff, or
management practices (i.e. choice of IVF vs ICSI, num-
ber of embryos transferred). However, one major differ-
ence between the two centers in our study is their
geographical environment: the Parisian center is sur-
rounded by 23 other IVF centers (9 in Paris itself and 14
in the suburbs), whereas the medium-sized city center isthe only one in this administrative area and the nearest
other center is in the city of Lyon, a 2-hour drive away.
Consequently, the medium-sized city center could be
defined as a monopoly center, whereas the Parisian one
competes with several other fertility centers. When there
are several fertility centers close to the woman’s place of
residence (a competition situation between centers), the
population of women who discontinue is probably
mixed, consisting of both patients with a poorer progno-
sis and patients who merely change IVF center, whatever
their prognosis. On the contrary, in a monopoly center,
as women cannot easily discontinue in order to begin
another IVF program elsewhere, most treatment discon-
tinuations are linked to poorer prognostic factors.
To the best of our knowledge, this is the first time that
the hypothesis of an association between treatment
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the IVF center has emerged in the literature. However, an
association between success and a monopoly situation or
competition between IVF centers has already been consid-
ered. Indeed, some studies have tested the association be-
tween an increasing number of multiple pregnancies and
competition between IVF centers, the underlying hypoth-
esis being that a greater number of embryos are transferred
in centers that compete against various others, in order to
maximize the chance of success [24,25]. Recently, a large
American study, conducted in clinics performing ART be-
tween 1995 and 2001 (n=2374 clinic-years), has examined
the relationship between competition and clinic-level ART
outcomes and practice patterns [26]. Defining competition
as the number of clinics within a 20-mile radius (32.19 km)
of a given clinic, they found no evidence of a significant re-
lationship between competition and birth rates in multi-
variate models. Moreover, they found a lower, rather than a
higher, rate of multiple births per ART cycle for clinics in
highly competitive areas, as has been suggested in one pre-
vious study using another definition for competition [27].
Our results are in agreement with the American study,
showing no difference between the two centers, one being
in a monopoly situation and the other in a competition
situation, with regard to chance of success.
Study limitations
In our model, we included only female age and center as
fixed effects. In the context of growing interest in under-
standing differences between IVF success rates according
to center [28,29], some studies have explored to what
extent such differences may be linked to differences in
patients’ characteristics. An English study has explored
the influence of patients’ characteristics on live birth rate
per cycle started [30]. The authors demonstrated the
impact of non-IVF related patient characteristics on
the success rate and concluded that using a “standard
patient group and outcome” did not improve validity of
comparisons between centers. More recently, using IVF
and ICSI treatment data from 11 IVF centers in the
Netherlands, Lintsen et al. studied how differences in
IVF success rates between centers could be explained
by patient characteristics and concluded that only 17% of
the variation between centers could be explained by pa-
tient mix [31]. Thus, there is currently no clear evidence
that other patient characteristics should be taken into ac-
count in our multivariate model. However, our shared
random effects model could be extended by including
temporal effects that could describe, for instance, the
patient’s level of discouragement due to psychological
and physical burden. Such a temporal effect could also
be included in the model to test if the link between the
success and treatment discontinuation processes may
also depend on the IVF attempt. Obviously, it would beof great interest to conduct such analysis on a greater
number of centers to better understand how the center’s
situation impacts on treatment discontinuation.
Study implications
Despite the increasing interest in understanding dif-
ferences in IVF success rates between IVF centers,
the reasons explaining such differences remain rather
unclear. It is likely that differences in IVF centers suc-
cess rates are a combination of patient and center char-
acteristics [32]. Treatment discontinuation rate could be
one of the factors impacting on the center success rate but
it has scarcely been investigated. In our study, we observed
two French centers with different crude success rates. After
controlling for the woman’s age and for the impact of dis-
continuation on success rate in a shared random effects
model, success rates between the two centers no longer
differed. Our results showed that discontinuation may be a
very important factor in explaining success rate differences
between centers, and it needs to be better understood.
Our study also enabled us to explore treatment dis-
continuation. Our main result was that discontinuation
appeared very dissimilar in the two centers. The center
strongly influenced the risk of treatment discontinuation
(unlike the chance of success). An important perspective
of this work will be to explore further the discontinua-
tion process and differences between centers in a larger
number of centers. Based on our results, a very promising
hypothesis would be to explore the possible influence of
the IVF center situation (monopoly/non-monopoly) on
the probability of treatment discontinuation. Our hypo-
thesis is that the probability of treatment discontinuation
decreased in centers that were in a monopoly situation.
Conclusion
Based on IVF treatment, we hypothesize that a better
understanding of the treatment discontinuation process
in relation to competition may be very helpful in under-
standing differences in success rates between IVF cen-
ters. It would be very interesting to explore if a similar
hypothesis would be pertinent for treatments other than
IVF, when patients have the possibility of deciding to
pursue their treatment in another medical center.
Additional files
Additional file 1: The appendix includes detailed information on
the shared random effects model.
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